Literature DB >> 7827213

24-hour lithium concentration in human brain studied by Li-7 magnetic resonance spectroscopy.

P Plenge1, A Stensgaard, H V Jensen, C Thomsen, E T Mellerup, O Henriksen.   

Abstract

Brain and serum lithium concentrations were measured every second hour during a 24-hr period following lithium intake, and again 48-hr later in two normal subjects in steady state lithium treatment receiving lithium carbonate (Priadel Synthelabo) once every evening. The brain-lithium concentration was measured by 7Li magnetic resonance spectroscopy (MRS). The brain lithium level was found to undulate in a peak-trough pattern that followed the serum lithium profile, although in an attenuated form. The brain/serum lithium concentration ratio varied considerably during the 48-hr period, ranging from 0.5 to 1.3, but the ratio was independent of the serum-lithium concentration. The median half-life for lithium was 28 hr in the brain, and 16 hr in serum. The brain lithium concentration in the morning was about 75% of the clinically relevant standard 12-hr serum lithium concentration. The finding that brain lithium undulates during the day means that MRS measurements of brain lithium can only be compared if carried out under standard conditions that include a fixed interval following lithium intake and an identical treatment regimen.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827213     DOI: 10.1016/0006-3223(94)90614-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  9 in total

1.  7Li 2D CSI of human brain on a clinical scanner.

Authors:  F Girard; T Suhara; T Sassa; Y Okubo; T Obata; H Ikehira; Y Sudo; M Koga; H Yoshioka; K Yoshida
Journal:  MAGMA       Date:  2001-08       Impact factor: 2.310

2.  The molecular basis of memory.

Authors:  Gerard Marx; Chaim Gilon
Journal:  ACS Chem Neurosci       Date:  2012-08-15       Impact factor: 4.418

3.  Twelve-hour brain lithium concentration in lithium maintenance treatment of manic-depressive disorder: daily versus alternate-day dosing schedule.

Authors:  H V Jensen; P Plenge; A Stensgaard; E T Mellerup; C Thomsen; H Aggernaes; O Henriksen
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

Review 4.  Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations.

Authors:  Gin S Malhi; Michelle Tanious
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

Review 5.  Lithium in bipolar disorder: can drug concentrations predict therapeutic effect?

Authors:  Beth Sproule
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

6.  Brain-to-serum lithium ratio and age: an in vivo magnetic resonance spectroscopy study.

Authors:  Constance M Moore; Christina M Demopulos; Michael E Henry; Ronald J Steingard; Linda Zamvil; Alain Katic; Janis L Breeze; JoEllyn C Moore; Bruce M Cohen; Perry F Renshaw
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

Review 7.  An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.

Authors:  Eunsoo Won; Yong-Ku Kim
Journal:  Int J Mol Sci       Date:  2017-12-11       Impact factor: 5.923

8.  Absence of Longer Reorientation Times in Patients Undergoing Electroconvulsive Therapy and Concomitant Treatment with Lithium.

Authors:  Ricardo Martins-Ascencao; Nuno Rodrigues-Silva; Nuno Trovão
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-11-30       Impact factor: 2.582

9.  Modulation of Gq/PLC-Mediated Signaling by Acute Lithium Exposure.

Authors:  Cesar Adolfo Sánchez Triviño; Maria Paula Landinez; Sara Duran; María Del Pilar Gomez; Enrico Nasi
Journal:  Front Cell Neurosci       Date:  2022-02-15       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.